Aquestive Therapeutics, Inc.
AQST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15 | -$14 | -$23 | -$17 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $2 | $2 | $2 |
| Change in WC | -$3 | $1 | -$5 | $5 |
| Other Non-Cash | $3 | $3 | $3 | $3 |
| Operating Cash Flow | -$13 | -$8 | -$23 | -$6 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $80 | -$0 | $21 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $0 | -$1 | $0 |
| Financing Cash Flow | $81 | -$0 | $21 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $69 | -$8 | -$3 | -$6 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $61 | $69 | $72 | $78 |
| End Cash | $129 | $61 | $69 | $72 |
| Free Cash Flow | -$13 | -$8 | -$24 | -$7 |